193 related articles for article (PubMed ID: 34719586)
21. Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers.
Bentz J; Ellens H
Methods Mol Biol; 2021; 2342():737-763. PubMed ID: 34272715
[TBL] [Abstract][Full Text] [Related]
22. [Absorption and transport of isoflavonoid compounds from Tongmai formula across human intestinal epithelial (Caco-2) cells in vitro].
Wang FR; Yang XW
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3206-3212. PubMed ID: 29171242
[TBL] [Abstract][Full Text] [Related]
23. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.
Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K
Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278
[TBL] [Abstract][Full Text] [Related]
24. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
[TBL] [Abstract][Full Text] [Related]
25. Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.
Chen Y; Xue F; Xia G; Zhao Z; Chen C; Li Y; Zhang Y
Food Funct; 2019 Aug; 10(8):5215-5227. PubMed ID: 31384856
[TBL] [Abstract][Full Text] [Related]
26. Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells.
Li H; Jin HE; Kim W; Han YH; Kim DD; Chung SJ; Shim CK
Pharm Res; 2008 Nov; 25(11):2601-12. PubMed ID: 18654741
[TBL] [Abstract][Full Text] [Related]
27. Effects of hypoxia on the expression and function of P-gp in Caco-2 cells.
Zhao A; Mu H; Yao W; Chang X; Li W; Wang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 48(4):491-498. PubMed ID: 37385611
[TBL] [Abstract][Full Text] [Related]
28. Trans-epithelial transport of the betalain pigments indicaxanthin and betanin across Caco-2 cell monolayers and influence of food matrix.
Tesoriere L; Gentile C; Angileri F; Attanzio A; Tutone M; Allegra M; Livrea MA
Eur J Nutr; 2013 Apr; 52(3):1077-87. PubMed ID: 22806766
[TBL] [Abstract][Full Text] [Related]
29. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
Wu SJ; Robinson JR
Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
[TBL] [Abstract][Full Text] [Related]
30. Transport of curcumin derivatives in Caco-2 cell monolayers.
Zeng Z; Shen ZL; Zhai S; Xu JL; Liang H; Shen Q; Li QY
Eur J Pharm Biopharm; 2017 Aug; 117():123-131. PubMed ID: 28396278
[TBL] [Abstract][Full Text] [Related]
31. Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein.
Liu Y; Liu B; Zhang Y; Peng Y; Huang C; Wang N; Jiang J; Wang Q; Chang J
Eur J Pharm Sci; 2017 Jul; 105():150-158. PubMed ID: 28487144
[TBL] [Abstract][Full Text] [Related]
32. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
33. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
34. Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers: role of P-glycoprotein and a novel Na(+)-dependent organic cation transport mechanism.
Bleasby K; Chauhan S; Brown CD
Br J Pharmacol; 2000 Feb; 129(3):619-25. PubMed ID: 10711363
[TBL] [Abstract][Full Text] [Related]
35. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
[TBL] [Abstract][Full Text] [Related]
36. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
[TBL] [Abstract][Full Text] [Related]
37. Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers.
Li Y; Fawcett JP; Zhang H; Tucker IG
J Pharm Pharmacol; 2007 Apr; 59(4):503-11. PubMed ID: 17430633
[TBL] [Abstract][Full Text] [Related]
38. Transepithelial transport of rosuvastatin and effect of ursolic acid on its transport in Caco-2 monolayers.
Hua WJ; Fang HJ; Hua WX
Eur J Drug Metab Pharmacokinet; 2012 Sep; 37(3):225-31. PubMed ID: 22562361
[TBL] [Abstract][Full Text] [Related]
39. Transepithelial transport of Cerulenin across Caco-2 cell monolayers.
Fu DH; Liu ZL; Liu JS; Luo Y; Shu Y; Huang SH; Han ZM
Eur J Drug Metab Pharmacokinet; 2009; 34(2):67-72. PubMed ID: 19645214
[TBL] [Abstract][Full Text] [Related]
40. Transport of trans-tiliroside (kaempferol-3-β-D-(6"-p-coumaroyl-glucopyranoside) and related flavonoids across Caco-2 cells, as a model of absorption and metabolism in the small intestine.
Luo Z; Morgan MR; Day AJ
Xenobiotica; 2015; 45(8):722-30. PubMed ID: 25761590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
